1. Translational Genomics Group, Vall d’Hebron Institute of Oncology, Barcelona, Spain2Department of Medical Oncology, Hospital Clínic of Barcelona, Barcelona, Spain3Translational Genomics and Targeted Therapeutics in Solid Tumors, August Pi i Sunyer Biomedical Research Institute, Barcelona, Spain
2. Division of Clinical Studies, Clinical Trials and Statistics Unit, Institute of Cancer Research, London, England
3. Department of Medical Oncology, Hospital Clínic of Barcelona, Barcelona, Spain3Translational Genomics and Targeted Therapeutics in Solid Tumors, August Pi i Sunyer Biomedical Research Institute, Barcelona, Spain
4. Translational Genomics Group, Vall d’Hebron Institute of Oncology, Barcelona, Spain
5. University of Southern California Norris Comprehensive Cancer Center, Los Angeles, California
6. Novartis, Novartis Pharmaceuticals Corporation, East Hanover, New Jersey
7. GlaxoSmithKline Oncology, Collegeville, Pennsylvania
8. Department of Medical Oncology, Royal Marsden Hospital, London, England